Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of September 2022. The report is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding treasury share positions rather than a financial performance report.
| Security Type | Initial Balance | Transactions in Month | Final Balance |
|---|---|---|---|
| Common Shares (Treasury) | 8,603,466 | None | 8,603,466 |
| Common ADRs | 0 | None | 0 |
Material Changes
There were no material changes to the company's treasury share positions during the reporting period. The filing explicitly states that no securities and derivatives operations took place in August 2022 (the period referenced in the specific CVM instruction section) or the month of September 2022.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to confirming the absence of trading activity in the company's own securities.
Key Facts for Investor Verification
- AMBEV S.A. held 8,603,466 common shares in treasury as of the end of the reporting period.
- No transactions involving the company's own securities or derivatives occurred during the month.
- The report was signed by Lucas Machado Lira, Chief Financial and Investor Relations Officer, on September 08, 2022.
- This filing does not contain financial performance data; investors should refer to Form 20-F or quarterly earnings releases for revenue and profit metrics.